A resident takes a Covid-19 test as part of a mass screening programme in Hong Kong, on September 1. Photo: XinhuaA resident takes a Covid-19 test as part of a mass screening programme in Hong Kong, on September 1. Photo: Xinhua
A resident takes a Covid-19 test as part of a mass screening programme in Hong Kong, on September 1. Photo: Xinhua

Mainland-listed Hybribio involved in Hong Kong’s Covid-19 mass testing scheme eyes expansion

  • Hybribio, the parent of Hong Kong Molecular Pathology Diagnostic Centre, said the volume of work was less than anticipated
  • DNA samples from Hong Kong tests have not been sent to the mainland China, said director Kun Tit Sang

Topic |   Coronavirus pandemic
A resident takes a Covid-19 test as part of a mass screening programme in Hong Kong, on September 1. Photo: XinhuaA resident takes a Covid-19 test as part of a mass screening programme in Hong Kong, on September 1. Photo: Xinhua
A resident takes a Covid-19 test as part of a mass screening programme in Hong Kong, on September 1. Photo: Xinhua
READ FULL ARTICLE
Close
We need your support

Advertising helps us continue to provide quality content. Help support us by disabling your adblocker on our site.

How to whitelist us:
  1. 1
    Click on the AdBlock icon at the top right corner of your browser.
    For iOS, go to Settings/Safari/Content Blockers and turn it off.

    For Android, go to your Ad blocker app/Settings and turn it off.
  2. 2
    Click Enabled on this site until the text reads Disabled on this site.
  3. 2
    Click the cross icon on the top right corner to close this window and refresh the page.
  4. 3
    Click the cross icon on the top right corner to close this window and refresh the page.